Effect of hybrid peptides of cecropin a and melittin in an experimental model of bacterial keratitis

Cornea

Volumn 16, Issue 1, 1997, Pages 101-106

  Nos Barbera, Salvador ^b   Portoles, Marta ^a,c   Morilla, Antonio ^d   Ubach, Josep ^d   Andreu, David ^d   Paterson, Christopher A ^d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b University of Louisville School of Medicine   (United States)

^c Polymer Technology   (United States)

^d NONE

Author keywords

Antimicrobial peptides; Bacterial keratitis; Cecropin A; Melittin; Pseudomonas aeruginosa

Indexed keywords

CECROPIN A; GENTAMICIN; MELITTIN;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CORNEA STROMA; INFLAMMATION; KERATITIS; LIPID MEMBRANE; MALE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RABBIT;

EID: 0031024086     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-199701000-00017     Document Type: Article

References (38)

1. Kreger AS, Griffin OK. Physicochemical fractionation of extracellular cornea damaging proteases of Pseudomonas aeruginosa. Infect Immunol 1974;9:828-34.
2. Kassler E, Kennah HE, Brown SI. Pseudomonas protease: purification, partial characterization, and its effect on collagen, proteoglycan, and rabbit corneas. Invest Ophthalmol Vis Sci 1977;16: 488-97.
3. Ormerod LD, Smith RE. Contact lens-associated microbial keratitis. Arch Ophthalmol 1986;104:79-83.
4. Ormerod LD, Hertzmark E, Gomez DS, Stabiner RG, Schanzlin DJ, Smith RE. Epidemiology of microbial keratitis in Southern California: a multivariate analysis. Ophthalmology 1987;94:1322-33.
5. Alonso E, Mandelbaum S, Fox MJ, Forster RK. Ulcerative keratitis associated with contact lens wear. Am J Ophthalmol 1986;101: 429-33.
6. Baker NR, Minor V, Deal C, Shahrabadi MS, Simpson DA, Woods DE. Pseudomonas aeruginosa exoenzyme S is an adhesin. Infect Immunol 1991;59:2859-63.
7. Fletcher EL, Fleitszing SMJ, Brennan NA, Pier GB. The RPON gene product of Pseudomonas aeruginosa is required for adherence to the cornea. Invest Ophthalmol Vis Sci 1992;33(suppl):844.
8. Hazlett LD, Moon M, Berk R, Zheng Z. Proteinase K decreases Pseudomonas aeruginosa adhesion to wounded cornea. Exp Eye Res 1992;55:579-87.
9. Steiner RF. Current therapy for bacterial keratitis and bacterial conjunctivitis. Am J Ophthalmol 1991;112:10S-14S.
10. Davison CR, Tuft SJ, Dart JK. Conjunctival necrosis after administration of topical fortified aminoglycosides. Am J Ophthalmol 1991;111:690-3.
11. Cameron JA, Antonios SR, Cotter JB, Habash NR. Endophthalmitis from contaminated donor corneas following penetrating keratoplasty. Arch Ophthalmol 1991;105:54-9.
12. Gelender H, Rettich C. Gentamicin-resistant Pseudomonas aeruginosa corneal ulcers. Cornea 1984;3:21-6.
13. Pardos GJ, Gallagher MA. Microbial contamination of donor eyes: a retrospective study. Arch Ophthalmol 1992;100:1611-3.
14. Leibowitz HM. Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution in the treatment of bacterial keratitis. Am J Ophthalmol 1991;112:34S-47S.
15. Vajpayee RB, Gupta SK, Angra SK, Munjal A. Topical norfloxacin therapy in Pseudomonas corneal ulceration. Cornea 1991;10: 268-71.
16. Ohadi C, Litwin KL, Moreira H, et al. Anti-inflammatory therapy and outcome in a guinea pig model of Pseudomonas keratitis. Cornea 1992;11:398-403.
17. Wilson LA. Bacterial corneal ulcers. In: Duane TD, Jaeger EA, Forster RK, eds. Clinical ophthalmology. Vol 4. Philadelphia: Harper & Row, 1987:18.
18. Leibowitz HM, Ryan WJ, Kupferman A, DeSantis L. Bioavailability and corneal anti-inflammatory effect of topical suprofen. Invest Ophthalmol Vis Sci 1980;27:628-31.
19. Leibowitz HM, Kupferman A. Topically administered corticosteroids: effect on antibiotic-treated bacterial keratitis. Arch Ophthalmol 1980;98:1287-90.
20. Carmichael TR, Gelfand Y, Welsh NH. Topical steroids in the treatment of central and paracentral corneal ulcers. Br J Ophthalmol 1990;74:528-31.
21. Gritz DC, Kwitko S, Trousdale MD, Gonzalez VH, McDonnell PJ. Recurrence of microbial keratitis concomitant with anti-inflammatory treatment in an animal model. Cornea 1992;11:404-8.
22. Harbin T. Recurrence of a corneal Pseudomonas infection after topical steroid therapy: report of a case. Am J Ophthalmol 1964; 58:670-4.
23. Suie T, Taylor FW. The effect of cortisone on experimental Pseudomonas corneal ulcers. Arch Ophthalmol 1956;56:53-6.
24. Gritz DC, Lee TY, Kwitko S, McDonell PJ. Topical anti-inflammatory agents in an animal model of microbial keratitis. Arch Ophthalmol 1990;108:1001-5.
25. Boman HG, Hultmark D. Cell-free immunity in insects. Annu Rev Microbiol 1987;41:103-26.
26. Zasloff M. Magainins, a class of antimicrobial peptide from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci USA 1987;84: 5449-53.
27. Lehrer RI, Ganz T, Selsted ME. Defensins: endogenous antibiotic peptides of animal cells. Cell 1991;64:229-30.
28. Gunshefski L, Mannis MJ, Cullor JS, et al. In vitro antimicrobial activity of Shiva-11 against ocular pathogens. Cornea 1994;13: 237-42.
29. Schwab IR, Dries D, Cullor J, et al. Corneal storage medium preservation with defensins. Cornea 1992;11(5):370-5.
30. Wade D, Boman A, Wahlin B, et al. All D-amino acid-containing channel-forming antibiotic peptides. Proc Natl Acad Sci USA 1990;87:4761-5.
31. Andreu D, Ubach J, Boman A, et al. Shortened cecropin A-melittin hybrids. FEBS Lett 1992;296:190-4.
32. Andreu D, Pons M, Ubach J, et al. Antibacterial, conformational and membrane-active properties of small size cecropin A-melittin hybrids. In: Schneider CH, Eberle AN, ed. Peptides 1992. Leiden: ESCOM Science Publishers B.V., 1993:763-5.
33. Hyndiuk RA. Experimental Pseudomonas keratitis. Trans Am Ophthalmol Soc 1981;79:541-624.
34. McDonald TO, Shadduck JA. Eye irritation. In: Marzulli FN, Maibach HI, eds. Dermatotoxicology and pharmacology. Washington, DC: Hemisphere Publishing, 1977:139-91.
35. Andreu D, Merrifield RB, Steiner H, Boman HG. N-terminal analogs of cecropin A: synthesis, antibacterial activity and conformational properties. Biochemistry 1985;24:1683-8.
36. Ferńndez I, Ubach J, Reig F, Andreu D, Pons M. Effect of succinylation on the membrane activity and conformation of a short cecropin A-melittin hybrid peptide. Biopolymers 1994;34:1251-8.
37. Merrifield RB, Juvvadi P, Andreu D, Ubach J, Boman A, Boman HG. Retro and retroenantio analogs of cecropin-melittin hybrids. Proc Natl Acad Sci USA 1995;92:3449-53.
38. Portoles M, Nos-Barbera S, Andreu D. Oculotoxicity of cecropin A-melittin hybrid peptides. Proceedings of the 18th Cornea Research Conference. Boston, MA, 1993.